Yang, J.-T.; Lee, I.-N.; Huang, C.; Huang, H.-C.; Wu, Y.-P.; Chong, Z.-Y.; Chen, J.-C.
ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. Int. J. Mol. Sci. 2023, 24, 7703.
https://doi.org/10.3390/ijms24097703
AMA Style
Yang J-T, Lee I-N, Huang C, Huang H-C, Wu Y-P, Chong Z-Y, Chen J-C.
ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. International Journal of Molecular Sciences. 2023; 24(9):7703.
https://doi.org/10.3390/ijms24097703
Chicago/Turabian Style
Yang, Jen-Tsung, I-Neng Lee, Cheng Huang, Hsiu-Chen Huang, Yu-Ping Wu, Zhi-Yong Chong, and Jui-Chieh Chen.
2023. "ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression" International Journal of Molecular Sciences 24, no. 9: 7703.
https://doi.org/10.3390/ijms24097703
APA Style
Yang, J.-T., Lee, I.-N., Huang, C., Huang, H.-C., Wu, Y.-P., Chong, Z.-Y., & Chen, J.-C.
(2023). ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. International Journal of Molecular Sciences, 24(9), 7703.
https://doi.org/10.3390/ijms24097703